Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK's Karen Vousden to join BMS board

She will also serve on the pharma firm's Science and Technology Committee

Cancer Research UK's Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January.

Vousden is currently chief scientist at Cancer Research UK, as well as serving as group leader at the Francis Crick Institute in London, will also sit the pharma firm's Science and Technology Committee.

She has more than 30 years experience in cancer research and her previous roles have included director of the Beatson Institute for Cancer Research and leadership positions at the US National Cancer Institute.

Giovanni Caforio, BMS’ chairman and chief executive officer, said: "Karen is a world class cancer researcher and a highly accomplished leader in her field.

“Her understanding of cancer biology and immunology research will bring valuable insights to advancing our strategy and strong pipeline in oncology along with our broader pipeline of transformational medicines.”

18th September 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics